147 related articles for article (PubMed ID: 16034307)
1. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
Lindemann W; Richter S; Schilling MK
Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
[TBL] [Abstract][Full Text] [Related]
2. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
5. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
6. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
[TBL] [Abstract][Full Text] [Related]
8. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
9. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
10. Successful use of hirudin during cardiac surgery using minimized extracorporeal circulation in patients with heparin-induced thrombocytopenia.
Haneya A; Philipp A; Lehle K; Diez C; Rupprecht L; Kobuch R; Hirt SW; Zausig YA; Schmid C; Puehler T
Ann Thorac Surg; 2011 Aug; 92(2):724-6. PubMed ID: 21801930
[TBL] [Abstract][Full Text] [Related]
11. A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
Huhle G; Hoffmann U; Hoffmann I; Liebe V; Harenberg JF; Heene DL
Thromb Res; 2000 Aug; 99(4):325-34. PubMed ID: 10963783
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
[TBL] [Abstract][Full Text] [Related]
13. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass.
Liu H; Fleming NW; Moore PG
J Clin Anesth; 2002 Sep; 14(6):452-5. PubMed ID: 12393116
[TBL] [Abstract][Full Text] [Related]
15. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
Schneider T; Heuer B; Deller A; Boesken WH
Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
[TBL] [Abstract][Full Text] [Related]
16. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
Fischer KG; van de Loo A; Böhler J
Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report.
Beholz S; Grubitzsch H; Bergmann B; Wollert HG; Eckel L
Perfusion; 2000 Jun; 15(3):257-60. PubMed ID: 10866429
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.
Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Anguenot T; Bernard Y; Bassand JP
Am J Hematol; 1995 Sep; 50(1):20-5. PubMed ID: 7668220
[TBL] [Abstract][Full Text] [Related]
19. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
20. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
